Clarius »

Lyell Immunopharma shares owned by Clarius

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Clarius from 13F filings

Historical chart of Clarius investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Clarius consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Clarius

Quarter filed Position value Share count Share price at filing
2025-09-30 $324k 20k 16.24
2025-06-30 $169k 19k 8.84

More positions owned by Clarius

Paccar (PCAR)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Msci Intl (IDEV)
Dimensional Etf Trust Intl High Profit (DIHP)
Amazon (AMZN)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Fundamental Us S (FNDA)
Dimensional Etf Trust Us High Profitab (DUHP)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Starbucks Corporation (SBUX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Esg Awr Msci Usa (ESGU)

View all positions for Clarius

Top funds holding Lyell Immunopharma

Arch Venture Corp
MWG Management
Foresite Capital Management IV
Vanguard Group
Orland Properties
Almitas Capital
Foresite Capital Management V
venBio Partners
Citadel Advisors
Alphabet
BlackRock
Sc China Holding
Geode Capital Management
Millennium Management
Rbf Capital

View all funds holding Lyell Immunopharma